China’s Great Leap Into Biotech – Bloomberg
|
China's Great Leap Into Biotech
Bloomberg China wants to go big on biotech and already is marching into experimental gene therapy. Last year marked a milestone in cancer treatment: In August, the U.S. FDA approved Novartis AG's Kymriah, a CAR–T 1 therapy for children with acute lymphoblastic … |
